
Biotech firm BioGX to invest $5 million in Alabama growth plans
Birmingham-based molecular diagnostics company BioGX plans to expand its R&D and manufacturing capabilities at a new corporate headquarters location in Shelby County, where it will beef up its workforce. The Birmingham Business Alliance announced today that BioGX has purchased a building on Valleydale Road in Shelby County for the move from its current location at…

Auburn’s SiO2 launches production of high-tech COVID-19 vaccine vials
AUBURN, Alabama – Governor Kay Ivey joined leaders of SiO2 Materials Science and other officials at a ribbon-cutting ceremony today to mark the opening of a facility where the Auburn company has launched production of unique vials to be used in the delivery of COVID-19 vaccines. The milestone celebrated at SiO2’s new production facility comes…

Alabama’s robust bioscience sector steps into spotlight at BIO Alabama event
The bioscience industry has a far-reaching influence in communities across Alabama and beyond, a fact that’s been shown most recently in the fight against the COVID-19 pandemic. The state’s researchers and entrepreneurs have stepped up in a major way, with contributions that support diagnostic testing, potential treatments and vaccine development. The economic impact of Alabama’s…

Innovation Fund joins Auburn to support development of OraSecure saliva collection device for COVID testing
AUBURN, Alabama — The Alabama Department of Commerce and the City of Auburn’s Industrial Development Board have teamed to award $250,000 in funding to accelerate the development of OraSecure LLC’s breakthrough patent-pending saliva collection device intended to help in the ongoing battle against the novel coronavirus. The support will help OraSecure finalize the initial manufacturing…

Evonik opens advanced biomaterials facility in Birmingham with expansion
BIRMINGHAM, Alabama — Evonik announced today that it has successfully commissioned an advanced biomaterials facility in Birmingham that will support global demand for the use of its RESOMER-brand bioresorbable polymers with implantable medical devices and parenteral drug products. The expansion will also allow Germany-based Evonik to provide contract manufacturing services to customers seeking to outsource…


